195 related articles for article (PubMed ID: 24861254)
21. [Examples of practice: clinical trials for medical devices and their application: wound care].
Augustin M
Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):347-53; discussion 353. PubMed ID: 22818157
[TBL] [Abstract][Full Text] [Related]
22. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
23. Generating comparative evidence on new drugs and devices after approval.
Cipriani A; Ioannidis JPA; Rothwell PM; Glasziou P; Li T; Hernandez AF; Tomlinson A; Simes J; Naci H
Lancet; 2020 Mar; 395(10228):998-1010. PubMed ID: 32199487
[TBL] [Abstract][Full Text] [Related]
24. Safety and effectiveness considerations for clinical studies of visual prosthetic devices.
Cohen ED
J Neural Eng; 2007 Mar; 4(1):S124-9. PubMed ID: 17325410
[TBL] [Abstract][Full Text] [Related]
25. [Barriers to clinical studies involving medical devices].
Wente MN
Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):315-9; discussion 320-1. PubMed ID: 22818147
[TBL] [Abstract][Full Text] [Related]
26. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
27. Clinical investigations: taking a global approach, part I.
Schaefer JF; Jessup G
Med Device Technol; 1993 Nov; 4(9):38-43. PubMed ID: 10146503
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges.
Heinonen TM; Aamer M; Marshall C; Black DM; Tardif JC
Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):989-94. PubMed ID: 23030288
[TBL] [Abstract][Full Text] [Related]
29. European medical device regulation: a new era?
Donawa M
Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
[TBL] [Abstract][Full Text] [Related]
30. Cardiac resynchronization devices: the Food and Drug Administration's regulatory considerations.
Moynahan M; Faris OP; Lewis BM
J Am Coll Cardiol; 2005 Dec; 46(12):2325-8. PubMed ID: 16360066
[TBL] [Abstract][Full Text] [Related]
31. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.
Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
Ann Thorac Surg; 2012 Dec; 94(6):e163-8. PubMed ID: 23153480
[TBL] [Abstract][Full Text] [Related]
32. Medical device regulatory landscape: the imperative of finding balance.
Kaplan AV; Williams DO
Circ Cardiovasc Interv; 2012 Feb; 5(1):2-5. PubMed ID: 22337999
[No Abstract] [Full Text] [Related]
33. [Industry regulation and its relationship to the rapid marketing of medical devices].
Matsuoka A
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2012; (130):13-20. PubMed ID: 23243983
[TBL] [Abstract][Full Text] [Related]
34. US Congress considers new tracking system for medical devices after excessive recalls.
Epstein K
BMJ; 2012 Apr; 344():e2915. PubMed ID: 22529316
[No Abstract] [Full Text] [Related]
35. A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe.
Campillo-Artero C
Health Policy; 2013 Nov; 113(1-2):38-44. PubMed ID: 23602548
[TBL] [Abstract][Full Text] [Related]
36. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.
Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
Ann Thorac Surg; 2012 Dec; 94(6):2147-58. PubMed ID: 23153481
[TBL] [Abstract][Full Text] [Related]
37. FDA perspective on clinical trial design for cardiovascular devices.
Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
[No Abstract] [Full Text] [Related]
38. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
[TBL] [Abstract][Full Text] [Related]
39. Clinical trials in the new millennium.
DeMets DL
Stat Med; 2002 Oct; 21(19):2779-87. PubMed ID: 12325093
[TBL] [Abstract][Full Text] [Related]
40. Identifying optimal postmarket surveillance strategies for medical and surgical devices: implications for policy, practice and research.
Gagliardi AR; Umoquit M; Lehoux P; Ross S; Ducey A; Urbach DR
BMJ Qual Saf; 2013 Mar; 22(3):210-8. PubMed ID: 23322750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
